SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-017507
Filing Date
2019-04-01
Accepted
2019-04-01 17:26:30
Documents
7
Period of Report
2019-05-08
Effectiveness Date
2019-04-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv517684_def14a.htm DEF 14A 147855
2 GRAPHIC img1.jpg GRAPHIC 25770
3 GRAPHIC img2.jpg GRAPHIC 5906
4 GRAPHIC img3.jpg GRAPHIC 21337
5 GRAPHIC img4.jpg GRAPHIC 4614
6 GRAPHIC img5.jpg GRAPHIC 172686
7 GRAPHIC img6.jpg GRAPHIC 184115
  Complete submission text file 0001144204-19-017507.txt   720347
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 19721969
SIC: 2836 Biological Products, (No Diagnostic Substances)